ZEMPLAR® (paricalcitol)
... the dose can be decreased to 1 mcg three times a week. If a further dose reduction is required, the drug should be withheld as needed and restarted at a lower dosing frequency. 2.2 Chronic Kidney Disease Stage 5 in Adults Initial Dose Administer the dose of ZEMPLAR capsules orally three times a week ...
... the dose can be decreased to 1 mcg three times a week. If a further dose reduction is required, the drug should be withheld as needed and restarted at a lower dosing frequency. 2.2 Chronic Kidney Disease Stage 5 in Adults Initial Dose Administer the dose of ZEMPLAR capsules orally three times a week ...
COX-2 inhibitor article for exam (medscape)
... of thrombotic cardiovascular events, oedema and loss of blood pressure control in treated hypertensive patients when compared to classical NSAIDs. The increase in cardiovascular risk is greatest after about 18 months of use, and many of the newer COX-2 inhibitors have not been studied adequately ove ...
... of thrombotic cardiovascular events, oedema and loss of blood pressure control in treated hypertensive patients when compared to classical NSAIDs. The increase in cardiovascular risk is greatest after about 18 months of use, and many of the newer COX-2 inhibitors have not been studied adequately ove ...
Prescribing Information
... suicidal ideation) has been reported with EDURANT. Patients with severe depressive symptoms should seek immediate medical evaluation to assess the possibility that the symptoms are related to EDURANT, and if so, to determine whether the risks of continued therapy outweigh the benefits. During the Ph ...
... suicidal ideation) has been reported with EDURANT. Patients with severe depressive symptoms should seek immediate medical evaluation to assess the possibility that the symptoms are related to EDURANT, and if so, to determine whether the risks of continued therapy outweigh the benefits. During the Ph ...
Prescribing Information
... In clinical studies, Tracleer caused at least 3-fold upper limit of normal (ULN) elevation of liver aminotransferases (ALT and AST) in about 11% of patients, accompanied by elevated bilirubin in a small number of cases. Because these changes are a marker for potential serious hepatotoxicity, serum a ...
... In clinical studies, Tracleer caused at least 3-fold upper limit of normal (ULN) elevation of liver aminotransferases (ALT and AST) in about 11% of patients, accompanied by elevated bilirubin in a small number of cases. Because these changes are a marker for potential serious hepatotoxicity, serum a ...
animax® ointment - Dechra Veterinary Products
... The preparation is intended for local therapy in a variety of cutaneous disorders of dogs and cats; it is especially useful in disorders caused, complicated, or threatened by bacterial and/or candidal (monilial) infection. ACTIONS: By virtue of its four active ingredients, ANIMAX Ointment provides f ...
... The preparation is intended for local therapy in a variety of cutaneous disorders of dogs and cats; it is especially useful in disorders caused, complicated, or threatened by bacterial and/or candidal (monilial) infection. ACTIONS: By virtue of its four active ingredients, ANIMAX Ointment provides f ...
... children with mild asthma, and found a highly significant reduction in growth which had not caught up in the 5 months following discontinuation of treatment. Pedersen concluded that in the short-term (weeks) and intermediate-term (months), budesonide at doses of ≤400 µg·day-1 via Nebuhaler does not ...
Anti-fungal drug
... • A fungal infection of animals, including humans. • Common and a variety of environmental and physiological conditions can contribute to the development. • Initiation of persistent infections:• Inhalation of fungal spores • localized colonization of the skin • Therefore, mycoses often start in the ...
... • A fungal infection of animals, including humans. • Common and a variety of environmental and physiological conditions can contribute to the development. • Initiation of persistent infections:• Inhalation of fungal spores • localized colonization of the skin • Therefore, mycoses often start in the ...
Drugs for Parasitic Infections
... treated with flucytosine, pentamidine, fluconazole and sulfadiazine plus either azithromycin or clarithromycin (phenothiazines were also used) combined with surgical resection of the CNS lesion (TR Deetz et al, Clin Infect Dis 2003; 37:1304; S Jung et al, Arch Pathol Lab Med 2004; 128:466). A free-l ...
... treated with flucytosine, pentamidine, fluconazole and sulfadiazine plus either azithromycin or clarithromycin (phenothiazines were also used) combined with surgical resection of the CNS lesion (TR Deetz et al, Clin Infect Dis 2003; 37:1304; S Jung et al, Arch Pathol Lab Med 2004; 128:466). A free-l ...
Asthma
... Skin thinning and purpura are associated with the use of oral or inhaled high dose steroids. Low dose inhaled steroids did not produce significant thinning of skin. Capewell ...
... Skin thinning and purpura are associated with the use of oral or inhaled high dose steroids. Low dose inhaled steroids did not produce significant thinning of skin. Capewell ...
Kalydeco - Vertex Pharmaceuticals
... gene, 50% of patients were female and 97% were Caucasian; 221 received KALYDECO, and 132 received placebo from 16 to 48 weeks. The proportion of patients who prematurely discontinued study drug due to adverse reactions was 2% for KALYDECO-treated patients and 5% for placebo-treated patients. Serious ...
... gene, 50% of patients were female and 97% were Caucasian; 221 received KALYDECO, and 132 received placebo from 16 to 48 weeks. The proportion of patients who prematurely discontinued study drug due to adverse reactions was 2% for KALYDECO-treated patients and 5% for placebo-treated patients. Serious ...
Vitamin B12 Supplement (SDIS)
... with no evidence of toxicity.(15) Evidence from published studies indicates that 1000 ug daily produces satisfactory long-term results while, in some patients, 500 ug daily results in only borderline cobalamin concentrations.(16) Serum B12 concentrations should be monitored closely, especially durin ...
... with no evidence of toxicity.(15) Evidence from published studies indicates that 1000 ug daily produces satisfactory long-term results while, in some patients, 500 ug daily results in only borderline cobalamin concentrations.(16) Serum B12 concentrations should be monitored closely, especially durin ...
Seizure Management in Dogs and Cats
... The term idiopathic epilepsy, also known as primary or asymptomatic epilepsy, is used when there is no identifiable cause of seizures. The term inherited epilepsy is used when there is a genetic cause of seizures. It is felt than genetics plays an underlying role in idiopathic epileptic dogs. Epilep ...
... The term idiopathic epilepsy, also known as primary or asymptomatic epilepsy, is used when there is no identifiable cause of seizures. The term inherited epilepsy is used when there is a genetic cause of seizures. It is felt than genetics plays an underlying role in idiopathic epileptic dogs. Epilep ...
The Nebraska Medical Center Guidelines for Management of
... anidulafungin compared with caspofungin. Phlebitis (3.5-25% of patients) and elevated liver enzyme levels (115%) occur more often with caspofungin compared with micafungin and anidulafungin (< 8%) 4. Flucytosine has broad antifungal activity against most Candida species except C. krusei.1,4 Availabl ...
... anidulafungin compared with caspofungin. Phlebitis (3.5-25% of patients) and elevated liver enzyme levels (115%) occur more often with caspofungin compared with micafungin and anidulafungin (< 8%) 4. Flucytosine has broad antifungal activity against most Candida species except C. krusei.1,4 Availabl ...
Suggestion from clinicians
... rizatriptan, sumatriptan and zolmitriptan. All act on serotonin (5-HT) subclass 1B and 1D receptors, on extracerebral blood vessels and neurons respectively. The supposed mechanism of action is prevention of neurogenically sterile inflammatory responses around vessels and vasoconstriction. The newer ...
... rizatriptan, sumatriptan and zolmitriptan. All act on serotonin (5-HT) subclass 1B and 1D receptors, on extracerebral blood vessels and neurons respectively. The supposed mechanism of action is prevention of neurogenically sterile inflammatory responses around vessels and vasoconstriction. The newer ...
SW_QA_390_2_Oseltamivir_RRT
... decreases linearly with creatinine clearance (CrCl) (6). Oseltamivir is generally well-tolerated, but gastrointestinal side effects and dizziness may appear with increasing doses, particularly in patients with renal failure (7). However, oseltamivir has a wide safety margin so one source suggests th ...
... decreases linearly with creatinine clearance (CrCl) (6). Oseltamivir is generally well-tolerated, but gastrointestinal side effects and dizziness may appear with increasing doses, particularly in patients with renal failure (7). However, oseltamivir has a wide safety margin so one source suggests th ...
Memorandum
... group consisted of 80 &lay for the first 4 weeks and 400 ug /day thereafter. Subjects were required to return for monthly visits at which time various safety and efficacy measurementswere obtained. There were no serious adverse events reported for either Colloral or placebo. All adverseevents report ...
... group consisted of 80 &lay for the first 4 weeks and 400 ug /day thereafter. Subjects were required to return for monthly visits at which time various safety and efficacy measurementswere obtained. There were no serious adverse events reported for either Colloral or placebo. All adverseevents report ...
National Cutting Horse Association
... performance associations. It is less effective in the therapy of colic and endotoxemia than flunixin meglumine (Banamine®). An initial dose of 4.4 mg/kg every 12 hours for the first day of therapy is followed by 2.2 mg/kg once a day for several days. Due to drug accumulation from the slow excretion ...
... performance associations. It is less effective in the therapy of colic and endotoxemia than flunixin meglumine (Banamine®). An initial dose of 4.4 mg/kg every 12 hours for the first day of therapy is followed by 2.2 mg/kg once a day for several days. Due to drug accumulation from the slow excretion ...
Minax - Medicines.org.au
... Care should be taken if -blockers have to be discontinued abruptly in patients with coronary artery disease. Severe exacerbation of angina and precipitation of myocardial infarction and ventricular arrhythmias have occurred following abrupt discontinuation of -blockade in patients with ischaemic h ...
... Care should be taken if -blockers have to be discontinued abruptly in patients with coronary artery disease. Severe exacerbation of angina and precipitation of myocardial infarction and ventricular arrhythmias have occurred following abrupt discontinuation of -blockade in patients with ischaemic h ...
2012 פברואר ה
... preparations may decrease the effectiveness of latex contraceptive agents. Therefore, GYNO-DAKTARIN products should not be used concurrently with a latex condom or latex diaphragm. ...
... preparations may decrease the effectiveness of latex contraceptive agents. Therefore, GYNO-DAKTARIN products should not be used concurrently with a latex condom or latex diaphragm. ...
Crestor - PI
... 5 mg: Yellow, round, biconvex, coated tablets. Debossed “CRESTOR” and “5” on one side of the tablet. 10 mg: Pink, round, biconvex, coated tablets. Debossed “CRESTOR” and “10” on one side of the tablet. 20 mg: Pink, round, biconvex, coated tablets. Debossed “CRESTOR” and “20” on one side of the table ...
... 5 mg: Yellow, round, biconvex, coated tablets. Debossed “CRESTOR” and “5” on one side of the tablet. 10 mg: Pink, round, biconvex, coated tablets. Debossed “CRESTOR” and “10” on one side of the tablet. 20 mg: Pink, round, biconvex, coated tablets. Debossed “CRESTOR” and “20” on one side of the table ...
Dosing Guide
... A potentially life-threatening condition could result from concomitant serotonergic drug administration. Discontinue ULTIVA if serotonin syndrome is suspected. Continuous infusions of ULTIVA should be administered only by an infusion device. Interruption of an infusion of ULTIVA will result in rapid ...
... A potentially life-threatening condition could result from concomitant serotonergic drug administration. Discontinue ULTIVA if serotonin syndrome is suspected. Continuous infusions of ULTIVA should be administered only by an infusion device. Interruption of an infusion of ULTIVA will result in rapid ...
4.2 Posology and method of administration
... variability between individual patients. Therefore should be used with
caution in patients with mild to moderate hepatic impairment (see section 4.2).
All patients with hepatic impairment should be monitored closely for possible
undesirable effects (e.g., insomnia, dry mouth, seizures ...
... variability between individual patients. Therefore
Subuphine sublingual tablet ENG
... If a hepatic event is suspected, further biological and aetiological investigation is required. Depending upon the findings the medicinal product may be discontinued cautiously in order to prevent withdrawal symptoms and to prevent recurrent abuse. If the treatment is continued, the liver function s ...
... If a hepatic event is suspected, further biological and aetiological investigation is required. Depending upon the findings the medicinal product may be discontinued cautiously in order to prevent withdrawal symptoms and to prevent recurrent abuse. If the treatment is continued, the liver function s ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.